Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases
AbstractMetabolic syndrome (MetS) is a cluster of metabolic risk factors associated with central obesity, hyperglycemia, insulin resistance, dyslipidemia and high blood pressure. In recent decades, because of the remarkable increase in both prevalence and severity, MetS and its related diseases such as cardiovascular diseases (CVDs), obesity, hypertension and diabetes have become the main global burden and challenge in strategic management involving prevention and treatment. However, currently, the preventions and treatments based on pharmaceutical interventions do not provide a solution for MetS and its related diseases. Recently, gut microbiota showed clear evidence of preventing and/or treating MetS, shedding light on treating MetS and its related diseases through a completely different approach. In this review, we will interpret the effects of current pharmaceutical drugs used in preventing and treating MetS and its related diseases to understand remaining issues of those interventions. We will explore the possibility of developing gut microbiota as pharmabiotics in a completely new medication option for treating MetS and its related diseases. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Nguyen, T.T.B.; Jin, Y.Y.; Chung, H.-J.; Hong, S.-T. Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases. Molecules 2017, 22, 1795.
Nguyen TTB, Jin YY, Chung H-J, Hong S-T. Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases. Molecules. 2017; 22(10):1795.Chicago/Turabian Style
Nguyen, Thi Thanh Binh; Jin, Yan Yan; Chung, Hea-Jong; Hong, Seong-Tschool. 2017. "Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases." Molecules 22, no. 10: 1795.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.